Variant report
Variant | rs2931309 |
---|---|
Chromosome Location | chr8:62096568-62096569 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs11777469 | 0.95[ASN][1000 genomes] |
rs13249426 | 0.95[ASN][1000 genomes] |
rs13253027 | 0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs13263981 | 1.00[ASN][1000 genomes] |
rs13264358 | 0.85[ASN][1000 genomes] |
rs13278769 | 1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs1367974 | 1.00[JPT][hapmap] |
rs1817635 | 0.80[ASN][1000 genomes] |
rs1946593 | 1.00[ASN][1000 genomes] |
rs2052993 | 1.00[JPT][hapmap] |
rs2129351 | 1.00[ASN][1000 genomes] |
rs2919303 | 1.00[CHB][hapmap];0.82[JPT][hapmap] |
rs2919305 | 1.00[CHB][hapmap];0.82[JPT][hapmap] |
rs2931292 | 1.00[CHB][hapmap];0.82[JPT][hapmap] |
rs2931312 | 0.80[ASN][1000 genomes] |
rs2931322 | 1.00[JPT][hapmap] |
rs2931323 | 1.00[CHD][hapmap];0.81[GIH][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2931346 | 0.80[ASN][1000 genomes] |
rs2978492 | 0.80[ASN][1000 genomes] |
rs2978498 | 1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2978542 | 0.80[ASN][1000 genomes] |
rs2978543 | 0.80[ASN][1000 genomes] |
rs2978558 | 1.00[CHB][hapmap];0.82[JPT][hapmap] |
rs35741212 | 1.00[ASN][1000 genomes] |
rs35860978 | 1.00[ASN][1000 genomes] |
rs4144413 | 0.95[ASN][1000 genomes] |
rs6983455 | 1.00[JPT][hapmap] |
rs7017483 | 1.00[JPT][hapmap] |
rs7017626 | 1.00[JPT][hapmap] |
rs956969 | 1.00[ASN][1000 genomes] |
rs9650204 | 1.00[ASN][1000 genomes] |
rs9650205 | 1.00[JPT][hapmap];0.80[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv948922 | chr8:61818964-62475097 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
2 | nsv465698 | chr8:62036793-62179465 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Bivalent/Poised TSS Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
3 | nsv611426 | chr8:62036793-62179465 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
4 | nsv1026243 | chr8:62039073-62101123 | Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Strong transcription | Chromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
5 | nsv890949 | chr8:62073346-62141341 | Flanking Active TSS Weak transcription Enhancers Active TSS ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive region | 1 gene(s) | inside rSNPs | diseases |
6 | nsv1024432 | chr8:62086247-62898782 | Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:62096400-62096800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr8:62096400-62097400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |